To investigate the role of CD38 in hypertension and hypertension-induced vascular remodeling, mouse models of hypertension were established by administrating Ang II infusion (490 ng/min/kg) subcutaneously through osmotic pumps for 4 weeks. This evidence concerns the gene CD38 and hypertensive disorder.